➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Harvard Business School
Medtronic
McKinsey
Boehringer Ingelheim

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for D-glucose


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug D-glucose?

D-glucose is an investigational drug.

There have been 33 clinical trials for D-glucose. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2021.

The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and University of Maryland.

There is one US patent protecting this investigational drug and eighteen international patents.

Recent Clinical Trials for D-glucose
TitleSponsorPhase
Contribution of PET (Positron Emission Tomography) Scans for the Preoperative Assessment of Symptomatic Endometriosis Lesions: TEP-ENDORUNCentre Hospitalier Universitaire de la RéunionPhase 3
18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed TomographyEastern Health, CanadaPhase 3
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung NodulesCanary FoundationPhase 2

See all D-glucose clinical trials

Clinical Trial Summary for D-glucose

Top disease conditions for D-glucose
Top clinical trial sponsors for D-glucose

See all D-glucose clinical trials

US Patents for D-glucose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
D-glucose   Try Before You Buy Aqueous pigment dispersion and aqueous ink DIC CORPORATION (Tokyo, JP)   Try Before You Buy
D-glucose   Try Before You Buy Lubricant compositions containing beta-glucans BASF SE (Ludwigshafen, DE) Wintershall Holding GmbH (Kassel, DE)   Try Before You Buy
D-glucose   Try Before You Buy Liposomal mupirocin Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (Jerusalem, IL)   Try Before You Buy
D-glucose   Try Before You Buy Recombinant Escherichia coli for producing succinate acid and application thereof TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES (Tianjin, CN)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for D-glucose

Drugname Country Document Number Estimated Expiration Related US Patent
D-glucose European Patent Office EP3146028 2034-05-22   Try Before You Buy
D-glucose Japan JP2017516908 2034-05-22   Try Before You Buy
D-glucose World Intellectual Property Organization (WIPO) WO2015177150 2034-05-22   Try Before You Buy
D-glucose China CN106659795 2034-04-10   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Moodys
McKesson
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.